Search research articles
Contact Us
Filters
Showing results (221-230 of 279) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2013
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group
Gertjan J L Kaspers, Martin Zimmermann, Dirk Reinhardt, et al.
Blood
|
June 7, 2021
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia
Elena Boldrin, Enrico Gaffo, Alexandra Niedermayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International Study
Andishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Leukemia
|
August 6, 2022
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
Jan Zuna, Lenka Hovorkova, Justina Krotka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial
Christina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009
Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 21, 2019
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study
Anna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, et al.
British Journal of Haematology
|
February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children
Theodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
Hemasphere
|
June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia
Chiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
Stefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 279) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 16, 2013
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group
Gertjan J L Kaspers, Martin Zimmermann, Dirk Reinhardt, et al.
Blood
|
June 7, 2021
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia
Elena Boldrin, Enrico Gaffo, Alexandra Niedermayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International Study
Andishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Leukemia
|
August 6, 2022
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
Jan Zuna, Lenka Hovorkova, Justina Krotka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial
Christina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2025
Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009
Hanna Gottschalk, Anja Möricke, Valentino Conter, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 21, 2019
Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10-14 years as compared with those aged 15-17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study
Anna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, et al.
British Journal of Haematology
|
February 4, 2020
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children
Theodor Uden, Alice Bertaina, Jonas Abrahamsson, et al.
Hemasphere
|
June 12, 2023
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia
Chiara Palmi, Silvia Bresolin, Stefanie Junk, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group
Stefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Page
of 28